MUT-056399
CAS No. 1269055-85-7
MUT-056399 ( FAB-001 )
产品货号. M11129 CAS No. 1269055-85-7
A novel, highly potent inhibitor of the FabI enzyme of both Staphylococcus aureus and Escherichia coli.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
规格 | 价格/人民币 | 库存 | 数量 |
5MG | ¥1596 | 有现货 |
|
10MG | ¥2657 | 有现货 |
|
25MG | ¥4479 | 有现货 |
|
50MG | ¥6391 | 有现货 |
|
100MG | ¥8667 | 有现货 |
|
200MG | 获取报价 | 有现货 |
|
500MG | 获取报价 | 有现货 |
|
1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称MUT-056399
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述A novel, highly potent inhibitor of the FabI enzyme of both Staphylococcus aureus and Escherichia coli.
-
产品描述A novel, highly potent inhibitor of the FabI enzyme of both Staphylococcus aureus and Escherichia coli; shows activity against S. aureus strains, including MSSA, MRSA, linezolid-resistant, and multidrug-resistant strains with MIC90s of 0.03-0.12 ug/ml; also has active against coagulase-negative staphylococci with MIC90s of 0.12-4 ug/ml; active in vivo (19.3-49.6 mg/kg/day).Bacterial Infection Preclinical
-
同义词FAB-001
-
通路GPCR/G Protein
-
靶点Antibacterial
-
受体Antibacterial
-
研究领域Infection
-
适应症Bacterial Infection
化学信息
-
CAS Number1269055-85-7
-
分子量293.27
-
分子式C15H13F2NO3
-
纯度>98% (HPLC)
-
溶解度DMSO: ≥ 31 mg/mL
-
SMILESCCC1=CC(=C(C=C1F)OC2=C(C=C(C=C2)C(=O)N)F)O
-
化学全称Benzamide, 4-(4-ethyl-5-fluoro-2-hydroxyphenoxy)-3-fluoro-
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Escaich S, et al. Antimicrob Agents Chemother. 2011 Oct;55(10):4692-7.
产品手册
关联产品
-
Oxolinic acid
Oxolinic acid is a potent inhibitor of DNA gyrase and DNA synthesis, lead to DNA cleavage when extracted chromosomes are incubated with sodium dodecyl sulfate.
-
Genz 669178
A potent PfDHODH inhibitor that exhibits low nanomolar in vitro potency against DHODH from P falciparum, P vivax, and P berghei.
-
Terminolic acid
Terminolic acid is a pentacyclic triterpenoid glucoside isolated from Combretum racemosum,?can inhibit the pro-inflammatory cytokines by binding to receptor active site of IL-1β and IL-6, and enhance anti-inflammatory cytokines by binding to IL-4 receptor binding sites.